Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Heroin Dependence: full-pipeline trial registry
A small indexed set (12 trials) with no open enrollment listed right now.
Corpus placement: #1,429 of 28,707 conditions by registered trial count.
12 US clinical trials · none currently recruiting · #1,429 of 28,707 conditions by registered trial count
Heroin Dependence: 12 US clinical trials tracked, none currently recruiting.
Heroin Dependence is the subject of 12 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 5 are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most active sponsor is National Institute on Drug Abuse (NIDA), running 5 of these trials.
Enrollment posture brief
Registry condition heroin-dependence
OPEN 0 | RECR 0% | LATE 5 | EARLY 7 | RANK #1429 | SPON 5
Volume-matched condition peers
Nearest open-share peer: Adenocarcinoma of the Gastroesophageal Junction (0% recruiting · 8 trials)
Heroin Dependence has no open enrollment in this registry pull (12 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Heroin Dependence on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Heroin Dependence is recruiting below its size-band peers.
0 of 12 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Heroin Dependence research.
National Institute on Drug Abuse (NIDA) accounts for 5 of 12 trials (41.7%). 5 distinct sponsors appear on at least one study for this condition label.
-
Typical Heroin Dependence enrolment sits around 60 participants.
Median target enrolment is 60 among the 9 trials that report a genuine target (sentinel values excluded). 5 of those (55.6%) plan for fewer than 100 participants.
-
Heroin Dependence research is mostly interventional.
12 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Indexed trials (enrollment closed)
12 total, page 1 of 1
Buprenorphine/Naloxone Versus Clonidine for Outpatient Opiate Detoxification - 1
University of California, Los Angeles
NCT00032968
Treatment of Opioid/Heroin Dependence: Comparison of Three Medication Dosing Regimens
National Institute on Drug Abuse (NIDA)
NCT00218127
The Efficacy of Methadyl Acetate (LAAM) and Contingency Management Procedures for Treating Dual Opioid and Cocaine Abuse - 1
National Institute on Drug Abuse (NIDA)
NCT00158288
Directly Administered HIV Therapy in Methadone Clinics
Johns Hopkins University
NCT00279110
Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone
New York State Psychiatric Institute
NCT00577408
Study of Computer-Based Treatment for Drug Dependence
Yale University
NCT01315184
Reinforcing Effects of Intranasal (IN) Buprenorphine Versus Buprenorphine/Naloxone
New York State Psychiatric Institute
NCT01760473
Opiate Dependence: Combined Naltrexone/Behavior Therapy - 1
New York State Psychiatric Institute
NCT00238914
A Laboratory Model for Heroin Abuse Medications - 8
New York State Psychiatric Institute
NCT00000273
Buprenorphine and Naloxone Combination Study - 10
National Institute on Drug Abuse (NIDA)
NCT00015288
Effects of Buspirone in Opiate Withdrawal
National Institute on Drug Abuse (NIDA)
NCT00326235
Study Comparing Liquid and Tablet Buprenorphine Formulations - 5
National Institute on Drug Abuse (NIDA)
NCT00000302
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 6 |
| Phase 3 | 4 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Heroin Dependence records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Heroin Dependence trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Heroin Dependence page
12 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Heroin Dependence trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- National Institute on Drug Abuse (NIDA) sponsors the most Heroin Dependence trials on record, review their full trial history before evaluating a specific study. See National Institute on Drug Abuse (NIDA)'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Heroin Dependence condition card totals 12 registered trials; most-linked intervention Buprenorphine/naloxone; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.